Recombinant Human FASN Protein，His

Fatty acid synthase (FASN) is a crucial enzyme involved in the de novo synthesis of fatty acids, playing a vital role in lipid metabolism and energy balance within cells. Its primary function is to catalyze the biosynthesis of long-chain fatty acids from acetyl-CoA and malonyl-CoA precursors through a series of enzymatic reactions. Dysregulation of FASN activity is linked to various pathological conditions, including obesity, insulin resistance, and cancer progression, making it an important target for therapeutic intervention. Research has revealed that FASN is often overexpressed in several tumor types, contributing to the enhanced lipid biosynthesis that fuels cancer cell growth and proliferation. Given its significance, scientists are focusing on developing FASN inhibitors as potential anti-cancer agents to suppress tumor growth by disrupting lipid metabolism. Additionally, studies on recombinant FASN proteins aim to elucidate the detailed mechanisms of fatty acid synthesis, enzyme kinetics, and the role of FASN in cellular signaling pathways. By utilizing recombinant DNA technology, researchers can produce FASN and its variants for structural and functional analyses, providing insights into its regulation and identifying novel inhibitory compounds. This research not only enhances the understanding of fatty acid metabolism but also paves the way for innovative strategies in cancer therapy and metabolic disease treatment.